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2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a very toxic environmental pollutant that raises great public 
concern about its impact on human health. Recent studies indicate that laurel leaf extract exhibits antioxidant 
properties that can counter the toxic effects of certain compounds in the liver. The aim of this study was 
to assess how effective LE is against the toxicity of TCDD in a primary culture of rat hepatocytes. The 
extract (50 mg L-1, 100 mg L-1, and 200 mg L-1) was added to cultures alone or with TCDD (1.61 mg L-1 
and 3.22 mg L-1) for 48 hours. Cell viability was measured using the [3-(4,5-dimethyl-thiazol-2-yl) 2,5-
diphenyltetrazolium bromide] (MTT) assay and the lactate dehydrogenase (LDH) cytotoxicity assay, while 
oxidative damage was assessed by measuring total antioxidant capacity (TAC) and total oxidative stress 
(TOS). DNA damage was also analysed using the micronucleus (MN) assay of the cultured hepatocytes. 
TCDD alone lowered, and laurel extract had no effect on cell viability. TCDD also increased TOS and 
signifi cantly decreased TAC. It signifi cantly increased the frequency of micronucleated hepatocytes in a 
dose-dependent manner. In cultures exposed to LE alone, TOS did not change and TAC signifi cantly 
increased in a dose-dependent manner. Added to TCDD, laurel countered its toxic effects and showed 
protective effects against TCDD-mediated DNA damage. This points to the therapeutic potential of laurel 
against TCDD toxicity in the liver.
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Dioxins and dioxin-like aromatic hydrocarbons 
a re  indus t r i a l  by-produc t s ,  and  2 ,3 ,7 ,8 -
tetrachlorodibenzo-p-dioxin (TCDD) is one of the 
most toxic among them (1, 2). Its effects include 
dermal toxicity, immunotoxicity, hepatotoxicity, 
carcinogenicity, teratogenicity, and neurobehavioral, 
endocrine, and metabolic changes (3). Moreover, 
animal studies suggest increased incidence of several 
cancer types associated with TCDD treatment (4).
TCDD induces degeneration of hepatocytes (5) 
and promotes liver cancer (6). All these disorders 
involve a strong oxidative stress after TCDD exposure. 
Given their nature, research to fi nd an agent to protect 
hepatocytes against oxidative stress is focused on 
antioxidants (7).
Laurel (Laurus nobilis L.) has long been used for 
its astringent, healing, and diuretic properties (8). This 
plant is used in cooking and folk medicine for stomach 
ache, fl atulence, and gastric diseases in many parts of 
the world (9). Moreover, recent experimental results 
indicated that the laurel leaf extract (LE) exhibited 
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antibacterial properties (10). In addition, laurel bark 
extract inhibited lipid peroxidation (LPO) (11).
However, hepatoprotective effects of LE against 
TCDD - including the DNA damage - have not yet 
been investigated. In our present study, we examined 
the effects of LE on the viability, antioxidative 




TCDD (CAS No. 1746-01-6) was purchased from 
Sigma-Aldrich (Saint Louis, Missouri, USA). L. 
nobilis leaf samples for various extractions and 
processing experiments were collected from the 
Mersin-Silifke region in Turkey in May 2010. They 
were dried in the shade and crushed. After crushing, 
100 g of air dried leaf powder was extracted with 
ethanol (95 %; 40 °C to 60 °C) in a Soxhlet extractor 
for 18 h to 20 h, and the solution was evaporated to 
dryness under reduced pressure and controlled 
temperature using a rotary evaporator. The extract 
(6.85 g) was stored in a refrigerator at 4 °C in air-tight 
bottles until further use.
Animals
For the study we used male Sprague-Dawley rats 
200 g to 300 g of body weight, bred at the Medical 
Experimental Research Centre, Ataturk University, 
Turkey. All experiments were performed in accordance 
with the Guide for the Care and Use of Laboratory 
Animals (12). The study protocol was approved by 
the local ethics committee.
Hepatocyte isolation and cultivation
Rats (n=3) were sacrifi ced by CO2 overdose, and 
the livers were removed immediately. Hepatocytes 
were isolated using collagenase perfusion (13). The 
liver was perfused through the portal vein with 
calcium-free Hanks balanced salt solution to remove 
blood for about 10 min at a fl ow rate of 2.5 mL min-1. 
As soon as the liver became greyish brown in colour, 
a second buffer solution containing Hank’s balanced 
salt supplemented with 4 mmol L-1 calcium chloride 
and 0.5 mg mL-1 collagenase (Sigma-Aldrich) was run 
at the same rate until the liver appeared to have broken 
up. It was then minced into 3-mm to 4-mm pieces with 
a sterile scalpel. Following mechanical dissociation, 
the cells were fi ltered through gauze and centrifuged 
at 200xg for 5 min. Then the hepatocytes were 
collected in a medium containing bovine serum 
albumin and bovine insulin (Sigma-Aldrich). The cell 
suspension was filtered through gauze again and 
allowed to sediment for 20 min to eliminate cell debris, 
blood, and sinusoidal cells. The cells were then washed 
three times by centrifugation at 50xg and tested by 
Trypan blue for viability (always in the range of 82 % 
to 93 %). The hepatocytes were then suspended in a 
mixture of 75 % Eagle’s minimum essential medium 
and 25 % medium 199, supplemented with 10 % foetal 
calf serum containing streptomycin, penicillin, bovine 
insulin, bovine serum albumin, and NaHCO3 (2.2 mg) 
(Fluka AG, Germany). For the experimental procedure, 
hepatocytes were plated in multi-well tissue culture 
plates. The medium was changed 3 h to 4 h later. The 
effect of TCDD and LE was studied after 48 h of 
exposure in cultures maintained with a medium 
deprived of foetal calf serum, but supplemented with 
hydrocortisone hemisuccinate (14). Hepatocytes were 
cultured for additional 8 h before treated with TCDD 
and/or LE.
Cell treatment
After eight hours of plating, when primary 
hepatocytes adhered to the plate, culture media was 
aspirated and replaced with an equal volume of media 
supplemented with 1.61 mg L-1 or 3.22 mg L-1 TCDD 
and/or with 50 mg L-1, 100 mg L-1, or 200 mg L-1 LE 
and incubated in a CO2 incubator for 48 hours.
MTT assay
Cell viability was assessed using a modifi ed 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) test (15, 16). After the treatment with 
TCDD and/or LE, the hepatocytes were incubated 
with 0.7 mg mL-1 MTT at 37 °C for 30 min and 
washed with PBS. Blue formazan was extracted from 
the cells with isopropanol/formic acid (95:5) and 
spectrophotometrically determined at 560 nm.
LDH assay
Lactate dehydrogenase (LDH) activity was 
measured as an index of cytotoxicity, using an LDH 
kit (Bayer Diagnostics, France) adapted to the auto 
analyzer ADVIA 1650 (Bayer Corp., Tarrytown, NY, 
USA) and expressed as the percentage of extracellular 
LDH activity in the total activity on the plates (17).
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TAC AND TOS ASSAYS
After 48 h, supernatants were collected to measure 
the total antioxidant capacity (TAC) and total oxidant 
status (TOS) levels using commercially available kits 
(Rel Assay Diagnostics, Gaziantep, Turkey) (18). The 
major advantage of the TAC test is that it measures 
the antioxidant capacity of all antioxidants in a 
biological sample and not just the antioxidant capacity 
of a single compound. In this test, antioxidants in the 
sample reduce dark blue-green coloured ABTS radical 
to its colourless reduced ABTS form. The change in 
absorbance at 660 nm is related to total antioxidant 
level in the sample. The assay is calibrated with a 
stable antioxidant standard solution called Trolox 
Equivalent, that is a vitamin E analogue.
In the TOS, oxidants in the sample oxidise the 
ferrous ion-chelator complex to ferric ion. The 
oxidation reaction is prolonged by enhancer molecules, 
which are abundant in the reaction medium. The ferric 
ion forms a coloured complex with chromogen in an 
acidic medium. Colour intensity, which can be measured 
spectrophotometrically, is related to the total amount of 
oxidant molecules in the sample. The assay is calibrated 
with hydrogen peroxide, and the results are expressed 
in terms of micromolar hydrogen peroxide equivalent 
per litre (H2O2 Equiv / μmol L
-1). 
Micronucleus assay
Rat hepatocyte micronucleated cell frequency was 
measured using the method of Suzuki et al. (19). 
Immediately before the measurement, 10 μL to 20 μL 
of hepatocyte suspension was mixed with an equal 
volume of acridine orange (0.5 mg mL-1) and 4’,6-
diamidino-2-phenylindole dihydrochloride (10 μg
mL-1) solution for fl uorescent staining. Micronucleated 
cells were counted in 2000 well-isolated hepatocytes 
per animal using a fl uorescence microscope (BX-70, 
Olympus Co. Ltd., Tokyo, Japan). A single observer 
(F. Geyikoglu) counted and confi rmed hepatocytes 
with round or distinct micronuclei that stained like the 
nucleus, but whose diameter was one quarter or less 
than that of the nucleus.
Statistical analysis
The experimental data were analysed using one-
way analysis of variance (ANOVA) and Fischer’s least 
signifi cant difference (LSD) tests to determine whether 
any treatment signifi cantly differed from control or 
between each other. Results are presented as mean 
±SD, and the level of p<0.05 is regarded as statistically 
signifi cant.
RESULTS
Figure 1 shows cell viability measured by the MTT 
assay. Cells treated with TCDD concentrations of 
1.61 mg L-1 and 3.22 mg L-1 showed 20 % and 60 % 
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Figure 1  Cell viability in rat hepatocyte cultures maintained 
48 h in the presence of TCDD, LE and their 
combinations.
TCDD 1: 1.61 mg L-1 TCDD; TCDD 2: 3.22 mg L-1 
TCDD; LE 1: 50 mg L-1 of laurel leaf extract; LE 2: 
100 mg L-1 of laurel leaf extract; LE 3: 200 mg L-1 
of laurel leaf extract; means of fi ve measurements 
marked by different letters differ significantly 
(P<0.05).
TCDD-induced hepatocellular damage was clearly 
evidenced by increases in LDH levels compared to 
controls. LE alone did not affect LDH activity (Figure 
2). Moreover, at the concentrations of 100 mg L-1 and 
200 mg L-1, LE significantly reduced TCDD 
toxicity.
Table 1 shows the effects of LE on biochemical 
parameters in all experimental groups. Hepatic TAC 
levels decreased (p<0.05) in TCDD-treated groups 
while TOS increased. In contrast, cells treated with 
LE alone at 100 mg L-1 and 200 mg L-1 showed higher 
antioxidant capacity than other groups but TOS levels 
were similar to control. Moreover, LE at 100 mg L-1 
and 200 mg L-1 signifi cantly (p<0.05) increased the 
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TAC level compared to hepatocytes treated with 
TCDD alone.
Table 2 shows the frequency of micronucleated rat 
hepatocytes. Compared to control, TCDD statistically 
increased their frequency, while LE did not affect it. 
Moreover, it countered the TCDD effects in a clear 
dose-dependent manner.
Table 1  Extracellular TAC and TOS levels in cultured rat hepatocytes incubated with TCDD and/or LE and in control culture. 
TCDD 1: 1.61 mg L-1 TCDD; TCDD 2: 3.22 mg L-1 TCDD; LE 1: 50 mg L-1 of laurel leaf extract; LE 2: 100 mg L-1 of 
laurel leaf extract; LE 3: 200 mg L-1 of laurel leaf extract; means of fi ve measurements marked by different letters differ 
signifi cantly (P<0.05).
Treatments TAC
Trolox Equiv. / mmol L-1
TOS
H2O2 Equiv. / μmol L
-1
Control 5.1±0.5b 8.3±2.1a
TCDD 1 4.1±0.6c 11.4±2.6c
TCDD 2 3.4±0.4d 16.4±2.9e
LE 1 5.0±0.5b 8.0±2.8a
LE 2 5.6±0.7a 8.4±2.7a
LE 3 5.8±0.6a 8.6±2.1a
TCDD 1 + LE 1 4.2±0.5c 11.0±2.9c
TCDD 1 + LE 2 4.6±0.7c 10.1±3.2b
TCDD 1 + LE 3 5.1±0.4b 9.4±2.5a
TCDD 2 + LE 1 3.5±0.4d 15.9±3.1e
TCDD 2 + LE 2 3.9±0.5cd 13.7±3.0d
TCDD 2 + LE 3 4.2±0.5c 13.0±2.6d
Figure 2  Extracellular level of LDH (as mU mL-1) in rat 
hepatocyte cultures maintained 48 h in the presence 
of TCDD, LE and their combinations. For 
abbreviations see legend in Figure 1.
Table 2 Percentage of micronucleated rat hepatocytes in 
cultures incubated with TCDD and/or LE and in control 
culture.
HEP = hepatocyte; MN cells = percentage of micronucleated 
hepatocytes per 2000 cells. TCDD 1: 1.61 mg L-1 TCDD; 
TCDD 2: 3.22 mg L-1 TCDD; LE 1: 50 mg L-1 of laurel leaf 
extract; LE 2: 100 mg L-1 of laurel leaf extract; LE 3: 200 mg
L-1 of laurel leaf extract; means marked by different letters 
differ signifi cantly (P<0.05).
Treatments MN cells /%  Range / %
Control 0.3±0.1a 0.2 to 0.4
TCDD 1 0.9±0.3c 0.7 to 1.3
TCDD 2 1.7±0.4d 1.5 to 2.3
LE 1 0.2±0.1a 0.1 to 0.3
LE 2 0.3±0.1a 0.2 to 0.4
LE 3 0.3±0.1a 0.2 to 0.4
TCDD 1 + LE 1 0.9±0.2c 0.7 to 1.4
TCDD 1 + LE 2 0.6±0.3b 0.4 to 0.8
TCDD 1 + LE 3 0.5±0.2b 0.4 to 0.7
TCDD 2 + LE 1 1.6±0.4d 1.3 to 2.0
TCDD 2 + LE 2 1.3±0.4cd 1.0 to 1.7
TCDD 2 + LE 3 1.1±0.2c 0.8 to 1.4
DISCUSSION
According to Hassoun et al. (20) and Jin et al. (21), 




















TCDD 1 + LE 1
TCDD 1 + LE 2
TCDD 1 + LE 3
TCDD 2 + LE 1
TCDD 2 + LE 2
TCDD 2 + LE 3
Extracellular LDH/total LDH
species (ROS) and LPO (20-21) in various tissues. This 
might be due to the inhibition of antioxidant enzyme 
activity (21). In contrast, Speroni et al. (8) have reported 
that LE exhibits high anti-radical activity. In fact it can 
restore the oxidant/antioxidant balance and lessen the 
destruction of cell membranes, proteins, and DNA, as 
has been confi rmed for other plants such as duckweed 
or dandelion (22, 23). Our results corroborate this 
antioxidant activity of laurel, also observed by 
Kaurinović et al. (24) and Conforti et al. (25); LE alone 
(at the concentrations of 100 mg L-1 and 200 mg L-1) 
signifi cantly increased TAC. In addition, supplemented 
to TCDD (1.61 mg L-1), LE restored TAC to control 
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levels. With higher LE doses the TAC increased by 
2.9 % to 24.3 %. Total antioxidant capacity combines 
the activities of non-enzymes such as glutathione (GSH) 
and enzymes such as superoxide dismutase (SOD), 
catalase (CAT), and glutathione peroxidase (GSH-Px) 
(26). The most abundant intracellular antioxidant, GSH, 
lowers endogenous ROS and/or exogenous oxidative 
damage in animal cells (27). GSH-Px enzyme 
metabolises peroxides such as H2O2 and protects cell 
membranes from LPO (28-29). According to Ralph et 
al. (30), amino acids may protect against toxicity by 
serving as precursors for GSH. GSH becomes depleted 
if cells are deprived of energy substrates. By providing 
an energy source and by acting as a precursor to GSH, 
LE may increase GSH content of hepatocytes and 
protect them from toxic substances. Recent reports also 
confi rmed the neuroprotective property of LE (31).
Anti-oxidative therapy has an important role in 
preventing hepatic damages (32-34). Dall’Acqua et 
al. (35) found ten different fl avonoid O-glycosides, 
one fl avonoid C-glycoside, catechin and cinnamtannin 
B1 in laurel leaf. All these compounds have antioxidant 
properties (35-37).
TCDD exposure is associated with increased 
production of ROS, lipid peroxidation, and DNA and 
membrane damage (38). ROS can alter vital cell 
components like polyunsaturated fatty acids, proteins, 
and nucleic acids (39). In our study, TCDD exposure 
increased the frequency of micronucleated rat 
hepatocytes. MN cell frequency lowered by LE in 
TCDD-treated cells may point to antioxidant activity 
in oxidative DNA damage (40). In a study by Ganguly 
(41), LE was a potent oxygen radical scavenger that 
improved carcinoma prognosis. Al-Kalaldeh et al. 
(42) evidenced antiproliferative activity of laurel 
extracts against human breast adenocarcinoma cells. 
Loizzo et al. (43) reported anticancer properties of LE 
in vitro against human amelanotic melanoma C32, 
renal cell adenocarcinoma ACHN, hormone-dependent 
prostate carcinoma LNCaP, and MCF-7 breast cancer. 
In addition, Hibasami et al. (44) isolated costunolide 
and zaluzanin D from laurel that proved to be effective 
against leukaemia HL-60 cells.
In conclusion, our fi ndings encourage the use of 
LE in diet as prevention of TCDD toxicity.
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Sažetak
BLAGOTVORNO DJELOVANJE EKSTRAKTA LOVOROVA LISTA NA HEPATOTOKSIČNOST U 
ŠTAKORA UZROKOVANU 2,3,7,8-TETRAKLORDIBENZO-P-DIOKSINOM IN VITRO
2,3,7,8-tetraklordibenzo-p-dioksin (TCDD) vrlo je toksičan onečišćivač okoliša koji izaziva veliku 
zabrinutost zbog mogućih posljedica za zdravlje ljudi. Nedavna su ispitivanja pokazala da ekstrakt lovorova 
lista (Laurus nobilis L.) ima antioksidacijska svojstva koja ublažavaju hepatotoksičnost. Cilj je ovog 
ispitivanja bio istražiti djelotvornost ekstrakta lovorova lista protiv toksičnoga djelovanja TCDD-a na 
primarnoj kulturi hepatocita. Kulturama je ekstrakt dodan u dozama od 50 mg L-1, 100 mg L-1 odnosno 
200 mg L-1 sam ili zajedno s TCDD-om u dozama od 1,61 mg L-1 odnosno 3,22 mg L-1. Izloženost je u 
oba slučaja trajala 48 h. Zatim je ispitana vijabilnost hepatocita s pomoću MTT-testa i testa na laktat 
dehidrogenazu (LDH). Oksidativno oštećenje mjerili smo s pomoću ukupnog antioksidativnoga kapaciteta 
i ukupnoga oksidativnog stresa. Oštećenje DNA hepatocita procijenjeno je s pomoću mikronukleus testa. 
MTT i LDH pokazali su da TCDD smanjuje vijabilnost hepatocita, ali ne i ekstrakt lovorova lista. TCDD 
je također povisio razinu ukupnoga oksidativnog stresa te smanjio ukupni antioksidativni kapacitet. Broj 
mikronukleusa rastao je s dozom TCDD-a. Nasuprot tomu, u hepatocitima izloženim samo ekstraktu 
lovorova lista nisu izmijenjene razine ukupnoga oksidativnog stresa, dok je ukupni antioksidativni kapacitet 
značajno rastao s dozom. Ekstrakt lovorova lista usto je ublažio toksično djelovanje TCDD-a na hepatocite 
u primarnoj kulturi. Stoga lovorov list štiti protiv oštećenja DNA uzrokovanoga TCDD-om. To ukazuje 
na mogućnost terapijske primjene ekstrakta lovorova lista protiv toksičnoga djelovanja TCDD-a u jetri.
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